Product
Indication
Discovery
Preclinical
IND Enabling
Clinical Trial
Rhea-001
Systemic fungal infections (Candidiasis, Aspergillosis), i.v.
Rhea-001
Systemic fungal infections (Candidiasis, Aspergillosis), i.v.
Rhea-002
MDR gram+ and gram- bacterial infections (N. gonorrhoeae, Staphylococcus aureus (VRSA), Clostridium difficile)
Rhea-002
MDR gram+ and gram- bacterial infections (N. gonorrhoeae, Staphylococcus aureus (VRSA), Clostridium difficile)
Rhea-003
Fungal and bacterial infections; topical
Rhea-003
Fungal and bacterial infections; topical
Rhea-004
Beta-Coronaviruses
Rhea-004
Beta-Coronaviruses
Rhea's Pipeline is Fit-for Purpose
Rhea-001
Rhea-001 has been discovered as a potent antifungal compound with activities against Fluconazole and Voriconazole- resistant Candida and Aspergillus strains. It will be developed mainly to treat severe systemic fungal infections.
More Information
Rhea-002
Rhea-002 is a novel small molecule with broad anti-bacterial activity, especially against multi-drug resistant MDR gram+ and gram- bacterial infections (such as N. gonorrhoeae, Staphylococcus aureus (VRSA), Clostridium difficile).
More Information
Rhea-003
Rhea-003 is a lead compound envisioned to be developed as a topical agent for both, fungal and skin infections.
More Information
Rhea-004
Rhea-004 is an antiviral compound which is in early stages of discovery for development as a pan-Coronavirus therapeutic. It is currently being explored as a nasal spray to prevent progression and transmission of coronaviruses causing the common cold, but also including pathogenic CoVs such as SARS-CoV-2.
More Information
CAREERS WITH US
Working at Rhea Pharmaceutical Sciences is a rewarding experience amongst a team of dedicated and experienced scientists aiming to develop novel medicines for patients with life-threatening infections. With effective company leadership and a basic collaborative approach, we welcome motivated individuals with great passion and talent who can help contribute to our core mission to help with the development of novel therapeutics.
We currently have no open positions, but if you like to get in touch, please submit your CV to: